INVO Bioscience OverviewINVO Bioscience EBIT
EBIT (Earnings Before Interest and Taxes) analysis for INVO.
Quarterly EBIT
-$1.59B
↑ 90.7% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$7.52B
↑ 72.67% YoY
Trailing 12 months ending Mar 31, 2026
INVO Bioscience OverviewEBIT (Earnings Before Interest and Taxes) analysis for INVO.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026